EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A recent decade update on combating doxorubicin-induced toxicities

Sruthi Sritharan, Nageswaran Sivalingam iD

Archives of Toxicology · 2025-09 · 99 (9) · 3565-3578

DOI: 10.1007/s00204-025-04112-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Toxicology, online erschienen am 02.07.2025. Verfasst von Sruthi Sritharan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of…. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: INSPIRE Fellowship, Department of Science and Technology, Ministry of Science and Technology, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gradual rise in global cancer rates every year instills the need for a reliable therapeutic strategy. Chemotherapy alone or in combination with surgery, radiation, or adjuvant therapy is still the preferred treatment option for a wide range of cancers. Doxorubicin (dox) is an extensively used chemotherapeutic anthracycline for combating a broad range of solid and soft-tissue tumors. However, dox therapy is often associated with undesirable side effects, mainly cardiotoxicity, limiting its clinical application. Over the years, many strategies have been developed to overcome these toxicities and improve the drug's therapeutic potential. This review is focused on discussing the recent investigations into natural compounds, nanoformulations, miRNAs, and physical exercise in protecting against dox-mediated cardiotoxicity, hepatotoxicity, nephrotoxicity, and neurotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinCardiotoxicityAntibiotics, AntineoplasticHumansAnimalsChemical and Drug Induced Liver InjuryNeurotoxicity SyndromesNeoplasms

Stichwörter der Autor:innen

CardiotoxicityChemotherapyDoxorubicinHepatotoxicityNephrotoxicity

Substanzen

DoxorubicinAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Biotechnology, School of Bioengineering, College of Engineering and Technology, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil…

ORCID-Profile: Nageswaran Sivalingam

Förderung

  • INSPIRE Fellowship, Department of Science and Technology, Ministry of Science and Technology, Government of India

Zitieren

APA

Sritharan, S., & Sivalingam, N. (2025). A recent decade update on combating doxorubicin-induced toxicities. Archives of Toxicology, 99(9), 3565-3578. https://doi.org/10.1007/s00204-025-04112-1

Vancouver

Sritharan S, Sivalingam N. A recent decade update on combating doxorubicin-induced toxicities. Archives of Toxicology. 2025;99(9):3565-3578. doi:10.1007/s00204-025-04112-1

BibTeX
@article{Sritharan2025,
  author = {Sritharan, Sruthi and Sivalingam, Nageswaran},
  title = {A recent decade update on combating doxorubicin-induced toxicities},
  journal = {Archives of Toxicology},
  year = {2025},
  volume = {99},
  number = {9},
  pages = {3565--3578},
  doi = {10.1007/s00204-025-04112-1}
}
Kostenlos starten →